Michel Favre

Publications

• Exploring Individual HPV Coinfections is Essential to Predict HPV-vaccination Impact on Genotype Distribution: a Model-based Approach
  Vaccine. Feb, 2013  |   Pubmed ID: 23246257
• Comparative Analysis of Virus-host Interactomes with a Mammalian High-throughput Protein Complementation Assay Based on Gaussia Princeps Luciferase
  Methods (San Diego, Calif.). Dec, 2012  |   Pubmed ID: 22898364
• EVER Proteins, Key Elements of the Natural Anti-human Papillomavirus Barrier, Are Regulated Upon T-cell Activation
  PloS One. 2012  |   Pubmed ID: 22761942
• Large Scale Genotype Comparison of Human Papillomavirus E2-host Interaction Networks Provides New Insights for E2 Molecular Functions
  PLoS Pathogens. 2012  |   Pubmed ID: 22761572
• Benchmarking a Luciferase Complementation Assay for Detecting Protein Complexes
  Nature Methods. Dec, 2011  |   Pubmed ID: 22127214
• Interleukin-36-receptor Antagonist Deficiency and Generalized Pustular Psoriasis
  The New England Journal of Medicine. Aug, 2011  |   Pubmed ID: 21848462
• Keratinocyte Sensitization to Tumour Necrosis Factor-induced Nuclear Factor Kappa B Activation by the E2 Regulatory Protein of Human Papillomaviruses
  The Journal of General Virology. Oct, 2011  |   Pubmed ID: 21715600
• [Investigation on HPV DNA Detection and Genotyping Practices Used in French Laboratories in 2009]
  Annales De Biologie Clinique. May-Jun, 2011  |   Pubmed ID: 21659046
• 疣状表皮発育異常症患者、親族、およびコントロールの 38 のヒトパピ ローマ ウイルス種類の Seroreactivity。
  The Journal of Investigative Dermatology. Mar, 2010  |   Pubmed ID: 19924140
• Effects of HPV-16 E5, E6 and E7 Proteins on Survival, Adhesion, Migration and Invasion of Trophoblastic Cells
  Carcinogenesis. Mar, 2010  |   Pubmed ID: 19917629
• The EVER Proteins As a Natural Barrier Against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections
  Microbiology and Molecular Biology Reviews : MMBR. Jun, 2009  |   Pubmed ID: 19487731
• Serological Relationship Between Cutaneous Human Papillomavirus Types 5, 8 and 92
  The Journal of General Virology. Jan, 2009  |   Pubmed ID: 19088282
• Role of Zn2+ Ions in Host-virus Interactions
  Journal of Virology. Dec, 2008  |   Pubmed ID: 18787005
• [Are Oncogenic Cutaneous HPVs Defective Commensals?]
  Médecine Sciences : M/S. May, 2008  |   Pubmed ID: 18466716
• Regulation of Cellular Zinc Balance As a Potential Mechanism of EVER-mediated Protection Against Pathogenesis by Cutaneous Oncogenic Human Papillomaviruses
  The Journal of Experimental Medicine. Jan, 2008  |   Pubmed ID: 18158319
• [Genetics and Business: in Defence of Free Speech!]
  Médecine Sciences : M/S. May, 2007  |   Pubmed ID: 17502073
• Human Papillomavirus Type 5 E6 Oncoprotein Represses the Transforming Growth Factor Beta Signaling Pathway by Binding to SMAD3
  Journal of Virology. Dec, 2006  |   Pubmed ID: 17020941
• Genomic Organization of Amplified MYC Genes Suggests Distinct Mechanisms of Amplification in Tumorigenesis
  Cancer Research. Feb, 2005  |   Pubmed ID: 15735000
• Severe Cutaneous Papillomavirus Disease After Haemopoietic Stem-cell Transplantation in Patients with Severe Combined Immune Deficiency Caused by Common Gammac Cytokine Receptor Subunit or JAK-3 Deficiency
  Lancet. Jun, 2004  |   Pubmed ID: 15207958
• Mutations in Two Adjacent Novel Genes Are Associated with Epidermodysplasia Verruciformis
  Nature Genetics. Dec, 2002  |   Pubmed ID: 12426567